Veracyte Inc (VCYT NASDAQ) stock market data APIs
$44.2596
-0.48(-1.1%)
as of December 8, 2025
Try our APIs with
free plan!
Veracyte Inc Financial Data Overview
Price chart is built with
Anychart
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Prev. Close
44.2596
Open
43.7803
High
44.8677
Low
43.601
52 wk Range
22.61-50.71
Market Cap
3 526 M
P/E Ratio
117.3947
Shares Outstanding
79 049 K
Revenue
495 M
EPS
0.51
Beta
1.83
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Veracyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Veracyte Inc data using free add-ons & libraries
Get Veracyte Inc Fundamental Data
Veracyte Inc Fundamental data includes:
- Net Revenue: 495 M
- EBITDA: 74 398 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: 0.3196
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Veracyte Inc News
New
Beat the Market the Zacks Way: Veracyte, Las Vegas Sands, 3M in Focus
Last Friday, the three most widely followed benchmark indexes closed a winning week. The S&P 500, the Dow Jones and the tech-heavy Nasdaq advanced 0.3%, 0.5% and 0.9%, respectively. This was the secon...
EHC Opens New Lake Worth Rehab Hospital to Meet Rising Demand
Encompass Health Corporation EHC recently opened its new Encompass Health Rehabilitation Hospital of Lake Worth, marking another milestone in the company’s rapid expansion across Florida. This facil...
Cathie Wood's Ark Invest weekly recap: Boosts AI and Crypto Bets, Trims Palantir, GitLab, and AMD
[Investment. Businessman using laptop and analyzing data with investment growth on stock markets, startups, real estate, technology, and financial trends on global network.] Harsa Maduranga/iStock via...
Cathie Wood's Ark Invest recap: pivots to AI drug discovery, gene editing stocks, reduces diagnostics and software exposure
[Bitcoin 2022 Conference Draws Cryptocurrency Industry Professionals And Investors To Miami] Marco Bello/Getty Images News During the last week, Cathie Wood’s ARK Invest reported strong buying in b...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
